Top compounds associated with response to EIF2S2


Feature Type Standardized
Nominal ANOVA
mRNA prima-1 CTRPv2 pan-cancer AAC -0.19 2e-09
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC -0.18 6e-08
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC -0.2 7e-08
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.19 1e-07
mRNA FK866 GDSC1000 pan-cancer AAC 0.15 2e-07
mRNA PX-12 CTRPv2 pan-cancer AAC -0.14 6e-07
mRNA Cerulenin CTRPv2 pan-cancer AAC -0.16 1e-06
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.14 2e-06
mRNA pac-1 CTRPv2 pan-cancer AAC -0.17 3e-06
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 3e-06
Download CSV